Nephros
NEPH
18 hedge funds and large institutions have $6.91M invested in Nephros in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
6% more funds holding
Funds holding: 17 → 18 (+1)
4.05% more ownership
Funds ownership: 40.65% → 44.7% (+4.1%)
6% less capital invested
Capital invested by funds: $7.33M → $6.91M (-$426K)
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$61.1K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$36.3K |
| 3 |
EP
Elkhorn Partners
Omaha,
Nebraska
|
+$7.6K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$41.8K |
| 2 |
BA
Bard Associates
Chicago,
Illinois
|
-$26K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$25.4K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.49K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$2.29K |
NEPH Hedge Fund Activity: Q4 2024 in Review
18 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q4 2024, worth a combined $6.91M — down 5.8% from $7.33M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NEPH positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 7 trimmed.
The largest buyer was UBS Group, adding an estimated $61.1K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $41.8K sold.
- 18 institutional investors held Nephros (NEPH) as of Q4 2024, up from 17 in Q3 2024.
- Funds reported $6.91M of Nephros stock for Q4 2024, down 5.8% quarter-over-quarter.
- 3 funds opened new Nephros positions in Q4 2024 and 2 closed out, a net change of +1 holder.
- The largest Nephros buyer in Q4 2024 was UBS Group, an estimated $61.1K added.
- The largest Nephros seller in Q4 2024 was Renaissance Technologies, an estimated $41.8K sold.
Based on aggregated 13F filings for Q4 2024.